[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Mirum Pharmaceuticals, Inc. Common Stock (MIRM)
Mirum Pharmaceuticals is set to acquire Bluejay Therapeutics for up to $XXX million, expanding its rare disease portfolio with a focus on hepatitis delta virus (HDV).
About Mirum Pharmaceuticals, Inc. Common Stock
Mirum Pharmaceuticals, Inc. is a biotechnology company focused on developing and commercializing novel therapies for liver diseases.
Mirum Pharmaceuticals, Inc. Common Stock uses the ticker $MIRM for trading. Listed in the Stocks category within the Healthcare sectors.
Insights
- Mirum Pharmaceuticals, Inc. Common Stock (MIRM) trading volume is up XXXXXX% from the previous week.
- Mirum Pharmaceuticals, Inc. Common Stock (MIRM) social dominance is up 1773.33% from the previous week.
- Mirum Pharmaceuticals, Inc. Common Stock (MIRM) Galaxy Score™ is up XXX% from the previous week.
- Mirum Pharmaceuticals, Inc. Common Stock (MIRM) creators is up XXXXX% from the previous month.
- Mirum Pharmaceuticals, Inc. Common Stock (MIRM) posts created is up XXXXXX% from the previous month.
- Mirum Pharmaceuticals, Inc. Common Stock Price hit a 52-Week high of $XXXXXX for the hour
- Mirum Pharmaceuticals, Inc. Common Stock Price hit an all time of $XXXXXX for the hour
Price: $XXXXX
Price 24-Hour Time-Series Raw Data
The stock is experiencing a bullish trend, hitting a 52-week high, driven by positive analyst recommendations and social media buzz regarding acquisitions and clinical trial progress. However, recent director share sales and a slight price decrease suggest potential short-term caution.
24-Hour: XXXX% 7-Day: -XXXX% 30-Day: -XXX%
1-Year High: $XXXXX on 2025-09-09
1-Year Low: $XXXXX on 2025-04-21
AltRank: XXXXX
AltRank 24-Hour Time-Series Raw Data
Mirum Pharmaceuticals, Inc. Common Stock (MIRM) is currently AltRank #1,095 based on combined combined social and market metrics
Daily Average: XXX
X Week: XXXXX -XXX
X Month: XXXXX -XXX
1-Year High: XXXXX on 2025-09-26
1-Year Low: XXX on 2025-08-17
Galaxy Score: XX
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
X Week: XX +30
X Month: XX +21
1-Year High: XX on 2025-09-20
1-Year Low: X on 2025-09-16
Engagements: XXXXX (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XXXXX
X Week: XXXXX -XX%
X Month: XXXXXX -X%
X Months: XXXXXXXXX +33%
X Year: XXXXXXXXX +64%
1-Year High: XXXXXXX on 2025-02-20
1-Year Low: XXX on 2025-04-13
Engagements by network (24h): News: XXX Reddit: X X: XXXXX
Mentions: XX (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
X Week: XXX +9%
X Month: XXX +57%
X Months: XXXXX +178%
X Year: XXXXX +73%
1-Year High: XXX on 2025-06-28
1-Year Low: X on 2025-04-13
Mentions by network (24h): News: XX Reddit: X X: XXX
Creators: XX (24h)
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning Mirum Pharmaceuticals, Inc. Common Stock (MIRM) in the last XX hours which is down XXXX% from XX in the previous XX hours
Daily Average: XX
X Week: XX +18%
X Month: XXX +51%
X Months: XXXXX +302%
X Year: XXXXX +173%
1-Year High: XXX on 2025-06-28
1-Year Low: X on 2025-04-13
The most influential creators that mention Mirum Pharmaceuticals, Inc. Common Stock in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @Andre_AGTC | X | XXXXX | X | XXX |
| @Biotech2k1 | X | XXXXXX | X | XX |
| @RebellioMarket | X | XXXXXXX | X | XX |
| @mirumpharma | X | XXX | X | XX |
| @CaseyVSilver | X | XXX | X | X |
Sentiment: XX%
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
X Week: XXX% no change
X Month: XXX% no change
X Months: XXX% +33%
X Year: XXX% +14%
1-Year High: XXX% on 2025-01-19
1-Year Low: XX% on 2025-03-06
Most Supportive Themes:
- Positive Analyst Recommendations and Buzz: (70%) Financial analysts and traders are issuing positive recommendations, contributing to significant social media buzz.
- Liver Disease Drug Research: (30%) Discussions highlight the company's focus on developing novel therapies for liver diseases and its potential for growth.
Most Critical Themes:
- Stock Performance Concerns: (100%) There are concerns regarding the stock's recent performance and potential associated risks.
Social Dominance: XXXXXX%
Social Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXX%
Daily Average: XXXXXXX%
X Week: XXXXX% +0.027%
X Month: XXXXXX% +0.0015%
X Months: XXXXXX% +0.0008999999999999998%
X Year: XXXXXX% -XXXXXX%
1-Year High: XXXX% on 2025-06-29
1-Year Low: XXXXXX% on 2025-10-24
Market Dominance: XXXXXXX%
Market Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXX%
Daily Average: X%
1-Year High: XXXXXXX% on 2025-09-08
1-Year Low: XXXXXXX% on 2025-07-31
Market Cap: $XXXXXXXXXXXXX
Market Cap 24-Hour Time-Series Raw Data
Current Value: $XXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXX
X Week: $XXXXXXXXXXXXX -$7.60%
X Month: $XXXXXXXXXXXXX -$7.30%
1-Year High: $XXXXXXXXXXXXX on 2025-09-09
1-Year Low: $XXXXXXXXXXXXX on 2025-07-31
Top Mirum Pharmaceuticals, Inc. Common Stock News
Top news links shared on social in the last XX hours
Showing a maximum of X news posts for non-authenticated requests. Use your API key in requests for full results.
"Mirum Therapeutics to buy Bluejay Therapeutics for up to $820M - San Francisco Business Times"
News Link @bizjournals 2025-12-10T01:05Z 228.6M followers, XXX engagements
Top Mirum Pharmaceuticals, Inc. Common Stock Social Posts
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"$MIST --nice X% breakout in prep for FDA approval; $PGEN --nice X% breakout on buyout speculation $MIRM --stabilizing as its new acquisition suggests it is "going it alone.""
X Link @Sean_Daly_ 2025-12-11T16:29Z XXX followers, XXX engagements
"Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)"
Reddit Link @Quantisnow 2025-12-11T00:15Z X followers, X engagements
"Novartis dropped this hepatitis drug years ago. Bluejay picked it up leading to a potential $XXX buyout by Mirum Pharmaceuticals - San Francisco Business Times via @SFBusinessTimes"
X Link @rleuty_biotech 2025-12-10T21:01Z 11.4K followers, XXX engagements
"#troutmanpepperlocke served as #intellectualproperty counsel for Mirum Pharmaceuticals Inc. in its acquisition of Bluejay Therapeutics a privately held biotechnology company focused on viral and liver diseases.#MergersAndAcquisitions Learn more:"
X Link @tpllaw 2025-12-10T14:10Z 5773 followers, XX engagements